Watch: the CureRays® explainer series
Prefer to read? The full guide below is complete on its own, with tables you can revisit any time.
What is eccrine carcinoma (sweat gland carcinoma)?
Eccrine carcinoma is an umbrella term for a rare group of skin cancers that develop from the eccrine sweat glands — the glands distributed across the skin that produce sweat to cool the body. Because the sweat gland has several parts, this group includes a number of distinct subtypes that behave differently, ranging from slow-growing and locally troublesome to more aggressive forms that can spread. They typically appear in middle-aged and older adults as a firm bump, nodule, or plaque on the head and neck, the scalp, the limbs, or the trunk, often growing slowly over months to years so that they are easy to mistake for a harmless skin growth. Several subtypes share a tendency to invade locally and deeply and to creep along the sheaths of nerves (perineural invasion), which means the cancer can extend well beyond what is visible and is prone to coming back if not treated widely enough. Some subtypes can also spread to nearby lymph nodes and, less often, to distant organs. Because these cancers are uncommon and varied, accurate diagnosis by an expert skin pathologist is essential — both to confirm that a tumor is an eccrine carcinoma rather than a benign sweat-gland growth or a cancer that has spread to the skin from elsewhere, and to identify the specific subtype, which guides treatment. The cornerstone of care is surgery to remove the tumor completely with a clear margin, frequently using margin-controlled (Mohs) techniques; radiation is an important partner, used to treat the microscopic disease these tumors leave behind, particularly along nerves, and as the main treatment when surgery isn't possible.
The main types
Doctors group eccrine carcinoma (sweat gland carcinoma) by where it starts and how it behaves:
| Type | What it means, simply |
|---|---|
| Microcystic adnexal carcinoma | A slow-growing but deeply infiltrating sweat-gland cancer, often on the face, that tracks along nerves and rarely spreads to distant sites; treated with wide or Mohs surgery and radiation along the nerve paths. (See its own detailed guide for more.) |
| Porocarcinoma | Arises from the sweat-gland duct, sometimes within a pre-existing benign poroma; most are cured by surgery, with radiation for high-risk tumors. (Covered in its own guide.) |
| Microcystic and ductal eccrine adenocarcinomas | Several related subtypes (such as eccrine ductal carcinoma and digital papillary adenocarcinoma, which favors the fingers and toes) that vary from indolent to capable of spreading; treated with complete surgery and radiation as the features dictate. |
| Aggressive / high-grade eccrine carcinoma | Less common subtypes with a higher tendency to invade, recur, and spread to lymph nodes or beyond; treated with surgery, radiation, and systemic therapy for advanced disease. |
Staging, in plain terms
Eccrine carcinomas are staged with the general skin-cancer TNM framework, which considers the size and depth of the tumor (T), whether it has spread to nearby lymph nodes (N), and whether it has reached distant organs (M). Because this is a varied group of rare cancers, however, two things matter as much as the stage number: the specific subtype and the detailed features the pathologist describes. Subtype is important because behavior differs widely — some, like microcystic adnexal carcinoma, are slow-growing and rarely spread to distant sites but invade deeply and track along nerves, while others are more aggressive and can reach the lymph nodes or beyond. The pathology features that shape treatment include how deeply the tumor invades, whether it is creeping along nerves (perineural invasion), how fast its cells are dividing, and whether the tumor was removed with a clear margin. Perineural invasion is especially significant for the sweat-gland cancers that favor it, because microscopic cancer can extend far beyond the visible tumor and dictates how widely surgery and radiation must reach. When these cancers do spread, they tend to go first to the lymph nodes draining the affected skin, so those nodes are evaluated for higher-risk tumors. The practical questions that guide care are: what subtype is it, how deep and aggressive is it, is it tracking along nerves, was it removed with a clear margin, and is there any sign it has reached the lymph nodes.
| Staged with the skin-cancer TNM framework — tumor size and depth (T), spread to nearby lymph nodes (N), distant spread (M) — with the specific subtype and the pathologist's risk features (depth, nerve invasion, dividing rate) strongly guiding treatment | What it generally means |
|---|---|
| Low-risk, localized | A thin, slow-growing tumor with no worrying features, removed completely; surgery alone is usually curative, with skin follow-up. |
| Locally infiltrating / high-risk | A deeply invasive tumor or one tracking along nerves; treated with wide or margin-controlled surgery, often followed by radiation, including along the nerve paths, to lower the chance of recurrence. |
| Spread to lymph nodes | Cancer found in nearby lymph nodes; treated with surgery to remove the nodes plus radiation, and systemic therapy considered. |
| Metastatic | Spread to distant organs (uncommon); managed with systemic therapy, with focused radiation or surgery for specific problem sites. |
The standard of care
Eccrine Carcinoma (Sweat Gland Carcinoma) is almost always treated by a team that may include a surgeon, a medical oncologist, and a radiation oncologist, combining therapies for the best result. The usual building blocks are:
Complete surgical removal
Cutting out the tumor with a clear margin of healthy tissue is the main treatment; because several subtypes invade deeply and along nerves, margin-controlled Mohs surgery is often used to be sure the edges are clear while sparing healthy skin.
Radiation therapy
Used after surgery to treat the microscopic disease these tumors leave behind — particularly along nerves — to lower the chance of recurrence, to treat lymph node areas, and as the main treatment when surgery isn't possible.
Expert dermatopathology and subtyping
Identifying the exact subtype and confirming it is a primary sweat-gland cancer (not a benign growth or a cancer spread from elsewhere) is essential, because the subtype determines how aggressively to treat and where to look for spread.
Lymph node evaluation
For higher-risk or aggressive subtypes, the lymph nodes draining the area are examined and imaged, and sometimes biopsied, because the nodes are the first place these cancers tend to spread.
Systemic therapy for advanced disease
For the uncommon cases that spread, systemic treatments are considered — sometimes guided by molecular testing of the tumor and often within a clinical trial, given how rare these cancers are.
How radiation treatment works
Radiation therapy treats eccrine carcinoma by delivering focused beams of energy that damage the DNA inside tumor cells so they can no longer grow and divide. Its role is shaped by a behavior several of these sweat-gland cancers share: rather than staying within the visible bump, they invade deeply and, in some subtypes, creep along the sheaths of nerves, leaving microscopic disease that extends well beyond what can be seen or felt. If only the obvious tumor were removed, those extensions — especially along nerves — could be left behind and seed a recurrence, which is why these cancers are prone to coming back if not treated widely enough. Radiation treats a wider zone, and for the nerve-tracking subtypes the field is deliberately extended to follow the course of the involved nerves, sterilizing microscopic disease that surgery cannot reach. This is the main reason radiation is so often paired with surgery here. It is given after surgery for tumors that invade deeply, track along nerves, or could not be removed with a comfortable clear margin, and it is also directed at the lymph nodes — after they are removed, or when they are involved — because the draining nodes are the first place these cancers tend to spread. When surgery is not a good option, focused radiation can serve as the main treatment, controlling the tumor and relieving symptoms. Because these cancers arise in the skin, radiation can often be delivered with techniques suited to surface targets, such as low-energy X-rays or electron beams, which concentrate the dose in the skin and the tissue just beneath while sparing deeper structures; for deeper or nerve-tracking disease, more penetrating, precisely shaped beams are used. Throughout, modern planning shapes the dose to cover the tumor, its bed, or the nerve pathway while limiting exposure to surrounding normal tissue, balancing effective treatment with a good cosmetic and functional result.
The main ways radiation is delivered for eccrine carcinoma (sweat gland carcinoma):
Postoperative (adjuvant) radiation
Radiation to the tumor bed after surgery sterilizes microscopic disease left behind, lowering the chance of recurrence for deeply invasive or nerve-tracking tumors or when margins are close.
Radiation along nerve pathways
For subtypes that creep along nerves, the radiation field is extended to follow the involved nerves' course, treating microscopic disease that surgery cannot see — a key reason radiation is paired with surgery in these cancers.
Nodal radiation
Radiation to the lymph node region after node surgery, or when nodes are involved, treats microscopic disease there and lowers the chance of regional recurrence.
Superficial / electron-beam radiation
For tumors confined to the skin, low-energy X-rays or electron beams concentrate dose at the skin surface while sparing deeper tissue, an efficient way to treat the target.
Latest studies shaping care
Care keeps improving — often toward getting the same excellent results with less burden on patients. A few developments:
Subtype drives behavior and treatment: Reviews of eccrine carcinomas show that behavior ranges widely by subtype — from slow-growing, locally infiltrating tumors to aggressive ones that spread — underscoring the importance of expert pathology to classify the tumor and tailor treatment.[1]
Clinicopathologic reviews of eccrine/adnexal carcinomas
Radiation improves control of nerve-tracking tumors: For sweat-gland cancers that invade deeply and creep along nerves, adding radiation after surgery — including along the nerve pathways — improves local control, supporting combined treatment for higher-risk tumors.[2]
Adjuvant radiotherapy series in adnexal skin cancers
Molecular testing and trials for advanced disease: Because these cancers are rare and systemic options limited, molecular profiling of the tumor is increasingly used to identify potential targeted treatments, and clinical trials are an important option for disease that has spread.[3]
Molecular-profiling and clinical-trial reports in adnexal carcinomas
Common questions
What does 'eccrine carcinoma' actually mean? It's an umbrella term for a rare group of skin cancers that begin in the eccrine sweat glands — the glands all over the skin that make sweat to cool the body. Because the sweat gland has several parts, this group includes a number of distinct subtypes that behave differently, from slow-growing tumors that mainly cause local trouble to more aggressive ones that can spread. That variety is why identifying the exact subtype is so important: it tells your team how aggressively the cancer is likely to behave, how widely to treat, and where to look for any spread. Some specific subtypes — such as microcystic adnexal carcinoma and porocarcinoma — are common enough to have their own detailed guides.
Why might radiation be aimed along a nerve? Several sweat-gland cancers have a habit of creeping along the sheaths of nerves, a pattern called perineural invasion. This lets microscopic cancer extend well beyond the visible tumor, following a nerve's path in a way that surgery can't fully see or remove. When the pathologist finds this, the radiation field is deliberately extended to follow the course of the involved nerve, treating the microscopic disease traveling along it. This is one of the main reasons radiation is paired with surgery for these tumors — it targets exactly the hidden extensions that would otherwise cause the cancer to come back.
Will surgery alone cure it? Often yes, especially for thin, slow-growing tumors with no high-risk features, which are usually cured by complete removal with a clear margin and then followed with skin checks. But because several subtypes invade deeply, track along nerves, or can reach the lymph nodes, additional treatment is added when the removed tumor shows those features or when the margin is close. In those cases radiation lowers the chance of the cancer returning, and the lymph nodes may be evaluated. The right plan depends on the specific subtype and what the pathology shows, which is why expert diagnosis is such an important first step.
References
Numbered sources for the studies cited above. Links open the primary publication on PubMed or the publisher’s site.
- Clinicopathologic reviews of eccrine/adnexal carcinomas (no indexed identifier — see your care team) ↩
- Adjuvant radiotherapy series in adnexal skin cancers (no indexed identifier — see your care team) ↩
- Molecular-profiling and clinical-trial reports in adnexal carcinomas (no indexed identifier — see your care team) ↩